PROCEPT BioRobotics Corporation
PRCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $83,327 | $79,182 | $69,162 | $68,236 |
| % Growth | 5.2% | 14.5% | 1.4% | – |
| Cost of Goods Sold | $29,321 | $27,436 | $25,001 | $24,564 |
| Gross Profit | $54,006 | $51,746 | $44,161 | $43,672 |
| % Margin | 64.8% | 65.4% | 63.9% | 64% |
| R&D Expenses | $18,187 | $17,632 | $16,402 | $15,066 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $59,011 | $56,303 | $55,197 | $48,316 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $77,198 | $73,935 | $71,599 | $63,382 |
| Operating Income | -$23,192 | -$22,189 | -$27,438 | -$19,710 |
| % Margin | -27.8% | -28% | -39.7% | -28.9% |
| Other Income/Exp. Net | $1,781 | $2,611 | $2,701 | $854 |
| Pre-Tax Income | -$21,411 | -$19,578 | -$24,737 | -$18,856 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21,411 | -$19,578 | -$24,737 | -$18,856 |
| % Margin | -25.7% | -24.7% | -35.8% | -27.6% |
| EPS | -0.38 | -0.35 | -0.45 | -0.35 |
| % Growth | -8.6% | 22.2% | -28.6% | – |
| EPS Diluted | -0.38 | -0.35 | -0.45 | -0.35 |
| Weighted Avg Shares Out | 55,727 | 55,445 | 54,917 | 53,838 |
| Weighted Avg Shares Out Dil | 55,727 | 55,445 | 54,917 | 53,838 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,700 | $3,506 | $3,578 | $3,333 |
| Interest Expense | $919 | $895 | $877 | $969 |
| Depreciation & Amortization | $1,618 | $1,588 | $1,475 | $1,453 |
| EBITDA | -$18,874 | -$17,095 | -$22,385 | -$16,434 |
| % Margin | -22.7% | -21.6% | -32.4% | -24.1% |